CloudMD Announces $10M Bought Deal

This evening CloudMD Software & Services Inc. (CSE: DOC) announced a $10M bought deal with a syndicate of underwriters co-led by Canaccord and Beacon. The underwriters agreed to purchase 14.3M units at a price of C$0.70 per unit with a full warrant priced at $1.00.

The stock has been on a role for the last month reaching a 52 week high of 95c.

The company also states they intend to use the proceeds of the offering for potential M&A activities to support their strategic growth plans and general corporate purposes.

The units will be offered by way of a short form prospectus and expected to close on June 2nd. The company granted the underwriters an option to purchase up to an additional 2.1M units at a price of C$0.70 per unit, exercisable at any time, for a period of 30 days after and including the closing date, which would result in additional proceeds of approximately C$1.5 million.

For full details, read the official company press release here.

The stock was halted all day and last traded at 77c.


FULL DISCLOSURE: CloudMD Software & Services is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover CloudMD Software & Services on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

Why Industrial Demand Is Changing the Silver Market | David Morgan

Gold and Silver Delivery Is Exposing the Paper Market | Andy Schectman

Recommended

Steadright To Acquire 75% Interest In Moroccan Copper-Lead-Silver Project

Nations Royalty Names Derrick Pattenden As President And CEO

Related News

Canadian Wholesale Trade Fell by 21.6% in April Amid Coronavirus Pandemic

The coronavirus pandemic caused many businesses across Canada to shut their doors, while consumers were...

Friday, June 19, 2020, 12:41:00 PM

Revive Expects To Complete Phase 3 Interim Analysis In December On Bucillamine In Treatment of COVID-19

Revive Therapeutics (CSE: RVV) provided an update on the status of its ongoing phase three...

Monday, October 26, 2020, 10:54:38 AM

CloudMD Taps 19 More Post-Secondary Institutions For Mental Health Support Program

CloudMD Software & Services Inc. (TSXV: DOC) announced today the partnership with 19 post-secondary institutions...

Tuesday, September 14, 2021, 09:46:00 AM

Coronavirus Pandemic Could Wipe Out Up To $30 Trillion from the Global Economy: McKinsey Global Institute

If production disruptions last for a span of at least 100 days amid the coronavirus...

Saturday, August 15, 2020, 11:16:00 AM

State Unemployment Benefits System Outsmarted by Foreign Scammers, Unemployed Americans

When the coronavirus suddenly impaired almost the entirety of the US economy, Congress had to...

Tuesday, June 2, 2020, 04:14:00 PM